JAK Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA) and an Inadequate Response or Intolerance to TNF Inhibitors (TNFi-IR)

  • Sponsored by AbbVie Medical Affairs
 Jul 01, 2022 9:00 am

×